多发性硬化
标志寄存器
医学
儿科
精神科
计算机科学
操作系统
作者
Holly A. Rutherford,Clarissa Martínez‐Rubio,Donald G. McLaren,Cynthia Cassandro,Ali Toumadj
出处
期刊:Neurology
[Lippincott Williams & Wilkins]
日期:2025-04-07
卷期号:104 (7_Supplement_1): 1822-
被引量:1
标识
DOI:10.1212/wnl.0000000000208767
摘要
Objective: To characterize leukodystrophy red flags for consideration of genetic testing in suspected MS patients. Background: Many adult-onset neurological disorders are inaccurately diagnosed as MS or other adult-onset leukodystrophies due to overlapping clinical/radiographic findings. Nearly 20–30% of patients who receive an initial diagnosis of MS have been misdiagnosed and ~40% of adult-onset genetic leukodystrophies, a family of monogenic white matter disorders with radiological and clinical findings, are often misdiagnosed as progressive forms of MS. Misdiagnosis of adult-onset leukodystrophies may be avoidable through identification of clinical or radiological findings suggestive of alternative diagnoses, and/or genetic testing for leukodystrophy-associated genes. While criteria exists to identify MS or high likelihood of MS once other diagnoses have been deemed unlikely, detailed characterization and awareness of ‘red flags’ to prompt consideration of alternate diagnoses and genetic testing in MS clinics are lacking. Design/Methods: A systematic literature review (PubMed, 1980–2024) to identify published case studies of adult-onset leukodystrophies with clinical presentations mimicking MS was conducted. Eligible publications were manually screened to identify those with clinical symptoms and brain imaging findings which may differentiate leukodystrophies from MS. Results: Fifty-nine (59) cases of adult-onset genetic leukodystrophies mimicking MS, many of whom were initially misdiagnosed were identified. Amongst those, CFS1R-ALSP was the most common final diagnosis (37.3%), followed by CADASIL (27.1%). Potential ‘red flags’ for differential diagnoses included family history of neurological disease, behavioral and cognitive changes, and/or atypical imaging findings. Conclusions: Adult-onset leukodystrophies are frequently misdiagnosed as MS due to overlapping clinical and radiological presentations. Several of the following red flags should prompt genetic testing for leukodystrophies: family history of neurological disorders, white matter abnormalities atypical of MS, and early-onset cognitive impairment with behavioral or motor dysfunction. Low cost or no cost genetic testing programs may expedite access to testing as needed. Disclosure: Miss Rutherford has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vigil Neuroscience. Dr. Martinez-Rubio has received personal compensation for serving as an employee of Vigil neuroscience. Dr. McLaren has received personal compensation for serving as an employee of Vigil Neuroscience. Dr. McLaren has received personal compensation for serving as an employee of Biogen. Dr. McLaren has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Pytri. Dr. McLaren has stock in Pytri. Dr. McLaren has stock in Biogen. Dr. McLaren has stock in Vigil Neuroscience. Dr. McLaren has stock in Voyager. An immediate family member of Dr. McLaren has stock in Biogen. An immediate family member of Dr. McLaren has stock in Seattle Genetics. Dr. McLaren has stock in Biohaven. Mrs. CASSANDRO has received personal compensation for serving as an employee of Vigil Neuroscience. Dr. Toumadj has received personal compensation for serving as an employee of Vigil Neuroscience. Dr. Toumadj has stock in Vigil Neuroscience. Disclaimer: Abstracts were not reviewed by Neurology® and do not reflect the views of Neurology® editors or staff.
科研通智能强力驱动
Strongly Powered by AbleSci AI